Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study

CompletedOBSERVATIONAL

Enrollment

758

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Axial SpondyloarthritisPsoriatic Arthritis

Interventions

DRUG

secukinumab

all patients who received secukinumab

Trial Locations (3)

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Novartis Investigative Site, Valencia